SRRM2 and Miyoshi myopathy: Patients with newly diagnosed MM were categorized into two groups, based on the level of SRRM2 expression on plasma cells: SRRM2-negative (SRRM2 expression < 30%, n = 6) and SRRM2-positive (SRRM2 expression ≥ 30%, n = 29).